Novartis Anorasikirwa neIndia Patent Nyaya; Vagadziri vezvinodhaka Vanobvumidzwa Kuenderera Kugadzira Glivac Generics
Novartis Anorasikirwa neIndia Patent Nyaya; Vagadziri vezvinodhaka Vanobvumidzwa Kuenderera Kugadzira Glivac Generics
Anonim

Dare Repamusorosoro reIndia rakapa mutongo wekuti vagadziri vezvinodhaka vemuno varambe vachigadzira mageneric eGlivac, mushonga wegomarara wekuchinja wakagadzirwa naNovartis, mushure mekuramba kuchengetedzwa kwepatent.

Kubvumidza patent kungadai kwakapa kambani yechipiri hombe yemishonga pasi rose mukana wekupinda mumusika uri kukura wemishonga uye kuwedzera purofiti; pachinzvimbo, mishonga yemuno ichabvumidzwa kuramba ichipa inokwanisika, yemhando yepamusoro mishonga yegomarara kune varombo veIndia.

Vanoda kusvika 30 muzana yeIndia inorarama muurombo, zvichiita kuti ruzhinji rwevanhu rutsamire pane dzimwe nzira dzakachipa.

Glivac ine patent mune dzimwe nyika makumi mana dzinosanganisira China, Russia neTaiwan, sekureva kwaNovartis. Inoshandiswa mukurapa kwekenza dzakawanda kusanganisira chronic myeloid leukemia. Mushonga uyu ndeye tyrosine-kinase inhibitor inodzivirira enzyme kuti itange kukura kwegomarara, pachinzvimbo ichi inokurudzira maseru egomarara kuti azviparadze.

"Novartis haasati ambopihwa patent yepakutanga yeGlivec muIndia. Isu tinotenda zvakasimba kuti hunyanzvi hwepakutanga hunofanirwa kuzivikanwa mumapatents kukurudzira kuisirwa mari muhunyanzvi hwekurapa kunyanya kune izvo zvisingaite zvinodiwa pakurapa," Ranjit Shahani, Mutevedzeri waSachigaro uye Managing Director weNovartis India Ltd.., yakataurwa mukutaura." Taunza nyaya iyi nokuti tinotenda zvakasimba kuti patents inochengetedza hutsva uye inokurudzira kufambira mberi mune zvekurapa, kunyanya kune izvo zvinodiwa pakurapa zvisina kukwana. Mutongo uyu unodzosera kumashure kuvarwere izvo zvinokanganisa kufambira mberi kwekurapa kwezvirwere pasina nzira dzekurapa dzinoshanda."

Kambani iyi yakatanga kuisa patent muna 1998 uye dare rakatonga kupokana nazvo muna 2006, richiti iyo inhibitor process yaitozivikanwa panguva iyoyo. Zvadaro, muna 2009, Novartis akamhan'arira imwe dare kudare, achipikisa mutongo wa2006.

Sekureva kwaNovartis, zviuru gumi nezvitanhatu zvevarwere muIndia vanoshandisa Glivac, uye 95 muzana yavo haibhadhare chero pairi. Novartis akataurawo kuti vanopfuura mazana matatu ezviuru varwere vekuIndia vanoshandisa iwo mageneric emushonga.

Glivac payakatanga kubvumidzwa neFDA muna 2001, mutengo we400mg wakamira pamadhora maviri, mazana mana muU.S.; ikozvino inotangira pamadhora matanhatu, 000 kusvika kumadhora manomwe, 000.

Parizvino, kambani yeSweden ndiyo yechipiri-inowana mari yakawanda kambani yemishonga munyika, ichitevera Pfizer chete. Iyo kambani yakabhenga $56.7 bhiriyoni mumari mu2012.

Yakakurumbira nenyaya